Toggle light / dark theme

Crew Dragon likely to support extended space station stay

WASHINGTON — SpaceX’s Crew Dragon spacecraft is performing well enough on orbit to give NASA confidence that the mission can last until August, an agency official said June 9.

Ken Bowersox, the acting associate administrator for human exploration and operations at NASA, told an online meeting of two National Academies committees that NASA had been monitoring the health of the Crew Dragon spacecraft since its launch May 30 on the Demo-2 mission, carrying NASA astronauts Bob Behnken and Doug Hurley to the International Space Station.

NASA, he noted, had not set a length for the mission, saying they wanted to see how the Dragon performed in space. “The Dragon is doing very well, so we think it’s reasonable for the crew to stay up there a month or two,” he told members of the Aeronautics and Space Engineering Board and Space Studies Board.

Help for Nicholi

Posted with permission by Eric Klien.

Hello everyone, as some of you may be aware about 6 years ago I was diagnosed with multiple myeloma and I published about it on Lifeboat Foundation’s blog. I was in remission but relapsed about a year ago. Going through radiation therapy as well as chemotherapy has taken its toll on my health and with the recent outbreak of Covid-19 has really put a lot of us in the high risk category. In order to stay safe i have avoided working for 3 months. Because of these unfortunate circumstances I am kindly requesting that anyone who is willing to help me get back on my feet to please help donate to my GoFund me page: https://www.gofundme.com/f/help-for-nicholi

I sincerely appreciate any and all help available. Thank you! I will post a link to my journey with cancer published on Lifeboat Foundation’s blog.


Due to the circumstances of Covid-19 and my medical condition (cancer) I took 3 month off of work. I am kindly requesting the help of others to help me stay on my feet until I am able to do so. Please message me for any other questions.

DonateShare.

Who’s to blame? These three scientists are at the heart of the Surgisphere COVID-19 scandal

I remember questioning this data, as it was not even research on animals, it was observation of people’s medical files.

Three unlikely collaborators are at the heart of the fast-moving COVID-19 research scandal, which led to retractions last week by The Lancet and The New England Journal of Medicine (NEJM), and the withdrawal of an online preprint, after the trove of patient data they all relied on was challenged. The three physician-scientists never were at the same institution nor had they ever before written together, but they are the only authors in common on the disputed papers, and the other co-authors all have ties to at least one of them. Their partnership, which seized a high-impact role during a global public health crisis, has now ended disastrously.

The first author for both retracted papers was cardiac surgeon Mandeep Mehra, an eminent Harvard University professor who works at Brigham and Women’s Hospital (BWH) and is known internationally for cardiovascular medicine and heart transplants. He provided the kind of gravitas that can fast-track papers to leading journals. In a statement provided by BWH, Mehra said he had met another of the trio, cardiac surgeon Amit Patel, in “academic and medical circles,” and that Patel had introduced him to Sapan Desai, a vascular surgeon and founder of Surgisphere, the tiny company that supplied the data. Journal disclosures, however, also indicate Mehra received compensation from Triple-Gene, a gene therapy company Patel co-founded to develop cardiovascular treatments.


Author partnership on coronavirus papers is “completely bizarre” and should have been a red flag, former journal editor says.

Essential components of dietary restriction revealed

Another link on diet/healthspan.


Studies by Monash Biomedicine Discovery Institute (BDI), have provided a new understanding into the roles two essential amino acids play in metabolic health, which may help scientists in the fight against obesity.

Led by Dr. Adam Rose, the recent finding, published in Nature Communications, shows that by reducing the amount of two —threonine and tryptophan—in young healthy mice, they were able to burn more calories than they consumed, without calorie reduction, keeping them lean and healthy and without the side-effect of lower muscle mass. A low-threonine even protected mice that were morbidly obese and prone to developing type 2 diabetes.

While a moderate reduction in dietary protein and therefore can enhance vitality, diets devoid of this component can make people sick very quickly and are not recommended. However, this study has shown that a reconsideration of the functions of these two amino acids in nutrition warrants further exploration.

Texas Reports Record-Breaking COVID-19 Hospitalizations As State Reopens

Guessing things are about to get dicey.


Texas reported a record-breaking number of COVID-19 hospitalizations Monday as the governor plans to reopen more businesses and double capacity.

Texas Department of State Health Services figures show 1,935 people were admitted as hospital patients for coronavirus-related treatment. That is up from a previous record of 1,888 on May 5.

The department’s new figures were released as Gov. Greg Abbott moves forward with a plan to open bars, restaurants, amusement parks and other businesses to 50% capacity.

Cuba credits two drugs with slashing coronavirus death toll

HAVANA HAVANA (Reuters) — Communist-run Cuba said this week that use of two drugs produced by its biotech industry that reduce hyper-inflammation in seriously ill COVID-19 patients has sharply curbed its coronavirus-related death toll.

Health authorities have reported just two virus-related deaths over the past nine days among more than 200 active cases on the Caribbean’s largest island, a sign they may have the worst of the outbreak under control.

The government, which hopes to increase its biopharmaceutical exports, has touted various drugs it produces for helping prevent infection with the new coronavirus and treating the COVID-19 disease it causes.

Bioactive inks printed on wearable textiles can map conditions over the entire surface of the body

Researchers at Tufts University’s School of Engineering have developed biomaterial-based inks that respond to and quantify chemicals released from the body (e.g. in sweat and potentially other biofluids) or in the surrounding environment by changing color. The inks can be screen printed onto textiles such as clothes, shoes, or even face masks in complex patterns and at high resolution, providing a detailed map of human response or exposure. The advance in wearable sensing, reported in Advanced Materials, could simultaneously detect and quantify a wide range of biological conditions, molecules and, possibly, pathogens over the surface of the body using conventional garments and uniforms.

“The use of novel bioactive inks with the very common method of screen printing opens up promising opportunities for the mass-production of soft, wearable fabrics with large numbers of sensors that could be applied to detect a range of conditions,” said Fiorenzo Omenetto, corresponding author and the Frank C. Doble Professor of Engineering at Tufts’ School of Engineering. “The fabrics can end up in uniforms for the workplace, sports clothing, or even on furniture and architectural structures.”

Wearable sensing devices have attracted considerable interest in monitoring human performance and health. Many such devices have been invented incorporating electronics in wearable patches, wristbands, and other configurations that monitor either localized or overall physiological information such as heart rate or blood glucose. The research presented by the Tufts team takes a different, complementary approach—non-electronic, colorimetric detection of a theoretically very large number of analytes using sensing garments that can be distributed to cover very large areas: anything from a patch to the entire body, and beyond.

IoT, AI and blockchain will change every aspect of enterprises and our lives: Oracle

The current health crisis has snowballed into a world economic crisis, where every old business norm has been challenged. In such times, we cannot fall back on old ways of doing our business. Today, three technologies

Internet of Things(IoT), Artificial Intelligence (AI), and blockchain are poised to change every aspect of enterprises and our lives. Now more than ever, organisations realise the pertinent need for a robust digital foundation for their businesses as their future plans have been disrupted. “To achieve that level of business sophistication holistically it is imperative that there is a seamless flow of data across all the functions of an enterprise. That requires connected data that is secure and one that is driven by connected intelligence,” Guruprasad Gaonkar, JAPAC SaaS Leader for ERP & Digital Supply Chain, Oracle told Moneycontrol in an interview:

How is India reacting to emerging technologies as compared to other Asia Pacific (APAC) regions?

Kitty Hawk ends Flyer program, shifts focus to once-secret autonomous aircraft

Kitty Hawk is shutting down its Flyer program, the aviation startup’s inaugural moonshot to develop an ultralight electric flying car designed for anyone to use.

The company, backed by Google co-founder Larry Page and led by Sebastian Thrun, said it’s now focused on scaling up Heaviside, a sleeker, more capable (once secret) electric aircraft that is quiet, fast and can fly and land anywhere autonomously.

Kitty Hawk is laying off most of Flyer’s 70-person team, TechCrunch learned. A few employees will be brought over to work on Heaviside, according to the company. Those who are laid off will receive at least 20 weeks of pay, plus tenure, depending on how long they were with the company. Former workers will also receive their annual bonus and have their health insurance covered through the end of the year. The company said it will set up placement services to help people find employment.

/* */